A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Clinical trial NCT06049290 · RECRUITING
Trial details
- NCT number
- NCT06049290
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2026-10-20
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.